Cyclacel Pharmaceuticals, Inc. (CYCC) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rebounds, but yield surge sets stage for weekly losses
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Form 10-Q Cyclacel Pharmaceuticals For: Jun 30
August 12, 2014 5:04 PM EDThttp://archive.fast-edgar.com/20140812/A422NQ2CZ226CZZ4222C2ZDZI3QUGZS2Z262 Filed on: August 12, 2014... More
Form 8-K Cyclacel Pharmaceuticals For: Aug 12
August 12, 2014 4:17 PM EDThttp://archive.fast-edgar.com/20140812/AW2X9Q2CZ226WZZ4222C2ZDZOUWEZZR2Z262 Filed on: August 12, 2014... More
